Targeting cervical cancer with anti-PD-1 antibodies: what is new?

被引：0
|
作者：
Greenman, Michelle [1 ]
Mcnamara, Blair [1 ]
Mutlu, Levent [1 ]
Santin, Alessandro D. [1 ,2 ]
机构：
[1] Yale Univ, Dept Obstet Gynecol & Reprod Sci, Sch Med, New Haven, CT USA
[2] Yale Univ, Obstet & Gynecol, Sch Med, 333 Cedar St, New Haven, CT 06520 USA
来源：
EXPERT OPINION ON BIOLOGICAL THERAPY | 2024年 / 24卷 / 03期
关键词：
cervical cancer; gynecologic malignancy; PD-1;
D O I：
10.1080/14712598.2024.2323596
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：111 / 114
页数：4
相关论文
共 50 条
  • [31] Role of Anti-PD-1 Antibodies in Advanced Melanoma: The Era of Immunotherapy
    Sahni, Sakshi
    Valecha, Gautam
    Sahni, Ankit
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2018, 10 (12)
  • [32] Anti-PD-1 Antibodies as a Therapeutic Strategy in Classical Hodgkin Lymphoma
    Jain, Michael D.
    Kuruvilla, John
    DRUGS, 2017, 77 (15) : 1645 - 1655
  • [33] Anti-PD-1 antibodies in metastatic uveal melanoma: a treatment option?
    Bender, Carolin
    Enk, Alexander
    Gutzmer, Ralf
    Hassel, Jessica C.
    CANCER MEDICINE, 2017, 6 (07): : 1581 - 1586
  • [34] The cessation of anti-PD-1 antibodies of complete responders in metastatic melanoma
    Ladwa, Rahul
    Atkinson, Victoria
    MELANOMA RESEARCH, 2017, 27 (02) : 168 - 170
  • [35] Dosage of anti-PD-1 monoclonal antibodies: a cardinal open question
    M. Sureda
    E. Calvo
    J. J. Mata
    V. Escudero-Ortiz
    E. Martinez-Navarro
    A. Catalán
    J. Rebollo
    Clinical and Translational Oncology, 2021, 23 : 1511 - 1519
  • [36] Neuromuscular adverse events associated with anti-PD-1 monoclonal antibodies
    Johansen, A.
    Christensen, S. J.
    Scheie, D.
    Hojgaard, J. L. Sunnleyg
    Kondziella, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 42 - 42
  • [37] Histopathologic Features of Colitis Due to Immunotherapy With Anti-PD-1 Antibodies
    Chen, Jonathan H.
    Pezhouh, Maryam K.
    Lauwers, Gregory Y.
    Masia, Ricard
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (05) : 643 - 654
  • [38] Anti-PD-1 Antibodies as a Therapeutic Strategy in Classical Hodgkin Lymphoma
    Michael D. Jain
    John Kuruvilla
    Drugs, 2017, 77 : 1645 - 1655
  • [39] Anti-PD-1 and Anti-PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes
    Mellati, Mahnaz
    Eaton, Keith D.
    Brooks-Worrell, Barbara M.
    Hagopian, William A.
    Martins, Renato
    Palmer, Jerry P.
    Hirsch, Irl B.
    DIABETES CARE, 2015, 38 (09) : E137 - E138
  • [40] Hypothalamic-Pituitary Autoimmunity in Patients Treated with Anti-PD-1 and Anti-PD-L1 Antibodies
    Bellastella, Giuseppe
    Carbone, Carla
    Scappaticcio, Lorenzo
    Cirillo, Paolo
    Troiani, Teresa
    Morgillo, Floriana
    Vietri, Maria Teresa
    Della Corte, Carminia Maria
    De Falco, Vincenzo
    Napolitano, Stefania
    Maiorino, Maria Ida
    De Bellis, Annamaria
    Esposito, Katherine
    CANCERS, 2021, 13 (16)
12345